New guidance expands the 'general wellness' exemption for wearables and loosens oversight of AI clinical decision tools — with major implications for every company building consumer neurotechnology.
The neuromodulation startup closed an oversubscribed Series C led by Morningside Ventures, pushing total funding to $233M as its pivotal Alzheimer's trial nears readout.
As China and the US race ahead in neurotechnology, India's premier research institute launches an AI brain co-processor project while analysts urge strategic preparation.
With 12+ patients implanted and mass production planned for 2026, Neuralink's clinical reality is more complicated and more human than the headlines suggest.
Backed by Mubadala and ARCH Venture Partners, the startup is merging AI diagnostics with FDA-cleared neuromodulation to consolidate fragmented psychiatric and neurological care.
A comprehensive review maps how brain signals measured during stroke recovery are converging with BCI systems and closed-loop neuromodulation to move rehabilitation beyond generic protocols toward individualized treatment.
Max Hodak's neurotechnology startup secures major funding round to bring its retinal implant system to market, signaling renewed investor confidence in sensory BCI applications.
Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.
The stablecoin giant invests in AI-powered sleep technology company Eight Sleep, extending a biotech investment strategy that began with its $200 million majority stake in Blackrock Neurotech.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.